Skip to main content
Premium Trial:

Request an Annual Quote

Sumitomo Completes $77M Acquisition of Oxford Finance

NEW YORK, June 15 (GenomeWeb News) - Sumitomo has completed its acquisition of Oxford Finance, which has backed several genomics companies, the companies said today.


Sumitomo Corporation of America, the US arm of the Japanese-based global trading giant, paid $77 million in cash and debt for Oxford Finance, according to the companies. The transaction, first announced Jan. 29, was approved in a May 28 shareholder meeting.


Oxford, privately held and based in Alexandria, Va., has provided financing to several life sciences tools companies, including US Genomics, Structural Genomix, and Cellular Genomics. The company said its has a total of 50 active portfolio companies.


Under the acquisition, Oxford will retain "operational independence," as well as its current management team," the companies said.


"With the closure of this transaction, Oxford will be able to provide its clients and venture capitalists with a direct link to the Japanese life science market for collaborative partnerships, distribution agreements and equity investments," Alden Philbrick, president and CEO of Oxford Finance, said in a statement.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.